AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rupp, J.
Right arrow Articles by Maass, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rupp, J.
Right arrow Articles by Maass, M.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2005, p. 406-407, Vol. 49, No. 1
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.1.406-407.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Serine-to-Asparagine Substitution in the GyrA Gene Leads to Quinolone Resistance in Moxifloxacin-Exposed Chlamydia pneumoniae

Jan Rupp,1 Andreas Gebert,2 Werner Solbach,1 and Matthias Maass1*

Institute of Medical Microbiology and Hygiene,1 Institute of Anatomy University of Luebeck, Luebeck, Germany2

Received 2 August 2004/ Returned for modification 12 August 2004/ Accepted 7 September 2004

Quinolone resistance of Chlamydia pneumoniae has not been described previously. Serial subcultures of C. pneumoniae under increasing moxifloxacin concentrations (0.0125 to 6.4 mg/liter) resulted in a 256-fold MIC increase compared to moxifloxacin-naive strains. GyrA gene sequencing revealed a novel point mutation with a Ser->Asn substitution. Subcultures under rifalazil and macrolides did not alter the respective MICs.


* Corresponding author. Mailing address: Institute of Medical Microbiology and Hygiene, University of Luebeck, Ratzeburger Allee 160, 23538 Luebeck, Germany. Phone: 49 (0)451 500 2822. Fax: 49 (0)451 500 2808. E-mail: matthias.maass{at}ukl.uni-luebeck.de.


Antimicrobial Agents and Chemotherapy, January 2005, p. 406-407, Vol. 49, No. 1
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.1.406-407.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.